Bioinformatics approach to predicting HIV drug resistance

Expert Review of Molecular Diagnostics
Frank CordesJoachim Selbig

Abstract

The emergence of drug resistance remains one of the most challenging issues in the treatment of HIV-1 infection. The extreme replication dynamics of HIV facilitates its escape from the selective pressure exerted by the human immune system and by the applied combination drug therapy. This article reviews computational methods whose combined use can support the design of optimal antiretroviral therapies based on viral genotypic and phenotypic data. Genotypic assays are based on the analysis of mutations associated with reduced drug susceptibility, but are difficult to interpret due to the numerous mutations and mutational patterns that confer drug resistance. Phenotypic resistance or susceptibility can be experimentally evaluated by measuring the inhibition of the viral replication in cell culture assays. However, this procedure is expensive and time consuming.

References

Oct 25, 1990·Nucleic Acids Research·T D Schneider, R M Stephens
Sep 1, 1995·Trends in Pharmacological Sciences·S M Green, G R Marshall
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·C D RosinD S Goodsell
Dec 4, 1993·Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management·W C Quinlan, N Majoros
Jul 16, 1999·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·H WalterK Uberla
Jan 25, 2002·AIDS·Cristina TuralUNKNOWN Havana Study Group
Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Niko BeerenwinkelJoachim Selbig
Dec 25, 2002·Bioinformatics·Sorin Drăghici, R Brian Potter
Aug 23, 2003·The Journal of Infectious Diseases·Dechao Wang, Brendan Larder
Aug 27, 2003·Statistics in Medicine·A Gregory DiRienzoKurt Hertogs
Oct 25, 2003·Antimicrobial Agents and Chemotherapy·Katharina WolfBarbara Schmidt
Feb 27, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott A WegnerUNKNOWN RV-125 Centers for Education and Research on Therapeutics Study Team
Mar 5, 2004·The New England Journal of Medicine·François Clavel, Allan J Hance
Apr 9, 2005·Trends in Microbiology·Ekachai JenwitheesukRam Samudrala
May 5, 2005·The Journal of Infectious Diseases·Niko BeerenwinkelRolf Kaiser
Jun 17, 2005·AIDS·Abdurrahman SagirDieter Häussinger
Feb 5, 2008·IEEE Transactions on Neural Networks·K R MüllerB Schölkopf
Mar 1, 2004·Health & Social Care in the Community·Anne Worrall-DaviesElizabeth Benson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.